Twist Bioscience Reports Fiscal First Quarter 2024 Financial Results [Yahoo! Finance]
Twist Bioscience Corporation (TWST)
Last twist bioscience corporation earnings: 2/6 04:05 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
— Increased FY 2024 revenue guidance to $288M to $293M; Increased FY 2024 gross margin guidance to 40% to 41% – SOUTH SAN FRANCISCO, Calif., February 02, 2024 BUSINESS WIRE Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today reported financial results and business highlights for the first quarter of fiscal 2024 ended December 31, 2023. "We're starting fiscal 2024 off strong with record revenue of $71.5 million for the first fiscal quarter, coming in above our projection, with a gross margin of 40.5%," said Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience. "In SynBio, after a limited launch of Express Genes in November, we expanded the offering to include midi and Maxi preps at Express speed and over time, we expect this offering will allow us to both expand our share of market and convert the Maker's Market of researchers who make their own genes i
Show less
Read more
Impact Snapshot
Event Time:
TWST
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TWST alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TWST alerts
High impacting Twist Bioscience Corporation news events
Weekly update
A roundup of the hottest topics
TWST
News
- Twist Bioscience: NGS Is Taking Off [Seeking Alpha]Seeking Alpha
- Twist Bioscience Co. (NASDAQ: TWST) had its price target raised by analysts at Evercore ISI from $46.00 to $50.00. They now have an "outperform" rating on the stock.MarketBeat
- Twist Bioscience Co. (NASDAQ: TWST) had its price target raised by analysts at Barclays PLC from $40.00 to $45.00. They now have an "overweight" rating on the stock.MarketBeat
- Twist Bioscience Corporation (NASDAQ:TWST) Q2 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Twist Bioscience Co. (NASDAQ: TWST) had its price target raised by analysts at Robert W. Baird from $39.00 to $40.00. They now have an "outperform" rating on the stock.MarketBeat
TWST
Earnings
- 5/2/24 - Beat
TWST
Sec Filings
- 5/3/24 - Form 144
- 5/3/24 - Form 144
- 5/3/24 - Form 144
- TWST's page on the SEC website